TP53 and cancer: However, in order to confirm the generality of the p53-dependent DPYD repression after cellular exposure to 5-FU, we used the A549, H460, U87MG and HT-1080 cancer cell lines that are wild-type for TP53 and trigger the expression of canonical p53 target genes.